This content is for Healthcare Professionals, by clicking “Proceed”
you are confirming you are a Healthcare Professional.

The current time to diagnosis of axial SpA in the UK averages approximately 8.5 years from symptom onset.¹ This delay is unacceptable and has consequences for patients.
With the Act on Axial SpA campaign, the National Axial Spondylarthritis Society (NASS) has proposed a roadmap for reducing the time from symptom onset to diagnosis to just one year.

1 in 200 of the adult population in the UK
have axial SpA. That’s twice as many as
multiple sclerosis and Parkinson’s disease.

Test your axial SpA
knowledge here >

How can cross sector collaboration
support in reducing time to diagnosis.

Watch Dr Hassan Tahir
and Dr Toby Wallace
discuss their perspective.

How do you know when you need to refer patients to rheumatology?

Listen to Dr Steven Zhao
and Dr Harry Petrushkin
on key signs to spot from an
ophthalmology perspective.

Axial SpA works silently, but we
need to ensure patients are heard.

Listen to Bethany
speak about her
journey to diagnosis.

“Diagnosing axial SpA is complex, with many patients having had their condition originally missed
or misdiagnosed. We are looking to change that narrative. Now that we are on year two of our
campaign, we want to ensure that healthcare professionals across primary and secondary care feel
confident in identifying and referring people to rheumatology clinics in a timely manner. The aim is
to establish a new standard of care where all patients receive a timely diagnosis, access treatments
earlier and live well in the prime of their life.”

Dr Dale Webb | CEO at NASS

Privacy Policy | © UCB Pharma Ltd 2023. All rights reserved. Date of preparation: February 2023. IE-N-DA-RH-2200113. This project is co-created by UCB and the National Axial Spondyloarthrtis Society and is funded by UCB. For UK/IRE healthcare professionals only.